Used in pharmaceutical research as a key intermediate for developing central nervous system agents, particularly in the synthesis of nicotinic acetylcholine receptor modulators. Shows potential in the treatment of neurological disorders such as Alzheimer's and Parkinson's disease due to its ability to cross the blood-brain barrier. Also investigated for use in compounds targeting depression and cognitive enhancement. Commonly employed in structure-activity relationship studies to optimize receptor selectivity and potency.